Practitioner working note presents a decision framework for CPOs' deployment strategies, highlighting options in congested markets.
European public DC charging networks average approximately 8% utilisation across portfolios against a widely cited 15% break-even threshold. The zones with the strongest utilisation potential in the Netherlands & Germany, in cities like Amsterdam, Rotterdam, Frankfurt, Berlin, and are exactly the zones where DSO connection queues run 36 months or longer. This creates a structural tension that the standard CPO deployment playbook does not resolve. This practitioner working note provides a decision framework for strategy and regulatory consultants advising charge point operators on deployment strategy in congested Dutch and German markets. The framework maps three deployment options, for new deployment in a congested zone, deployment in uncongested secondary city zones, and distributed connection architecture with battery energy storage, along with their real tradeoffs stated explicitly rather than optimised for any single recommendation. The note covers: the carry cost mechanics of a 36-month DSO connection delay on a per-site basis; the 49kW regulatory arbitrage retrofit liability in acquired CPO estates under AFIR Article 5 (EU 2023/1804); utilisation ramp modelling for secondary city deployment using municipal-level EV registration data; the distributed BESS connection architecture documented in the companion Paper 4 as a third option that changes the grid access equation; and a portfolio construction analysis identifying at what operator scale a mixed strategy becomes viable versus where sequential deployment is the more executable path. The framework does not recommend a single option universally. It identifies the capital structure, hold horizon, and regulatory conditions under which each option is the appropriate choice for a specific client situation. This brief is Document 5A in a practitioner series on EU EV charging regulatory and investment risk. Companion documents cover CPO acquisition due diligence for Chinese EVSE hardware exposure (Document 1), unpriced event risks in Chinese OEM EU exposure (Document 2), EU market entry sequencing for Chinese OEMs (Document 3), and Chinese industrial policy and EU market survivorship (Document 4).
No takes yet. Share an insight, caveat, or question.
Abhishek Arya (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: